|Buy Target – $2.70 or better|
|Sell Target – TradersPro Sell Signal|
Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as a fine spray into the oral cavity. The company is also developing AE37, a synthetic peptide vaccine to stimulate a potent and specific immune response against tumors with low levels of expression of the HER-2/neu oncogene in patients with breast cancer and prostate cancer. In addition, it develops, manufactures, and distributes rapid point-of-care in-vitro medical diagnostics for infectious diseases, such as human immunodeficiency virus, tuberculosis, malaria, hepatitis B, hepatitis C, syphilis, and others; and cassette devices.
5G Stock CRUSHES Earnings!!
Wall Street is loading up on shares of one 5G SuperStock (26 million shares purchased). Why? Because the stock brings in more cash than IBM, Facebook and even Google! Yet it trades for just $3. Get the scoop on the 5G SuperStock right here. [ad]